Dual anti-CTLA-4 and anti-PD-1 blockade in metastatic basal cell carcinoma

We report the basal cell cancer (BCC) cohort of the SWOG/NCI 1609 Dual Anti-CTLA-4 & Anti-PD-1 blockade in Rare Tumors (DART), a phase II prospective, multicenter basket trial of nivolumab and ipilimumab. The primary endpoint was objective response rate (ORR) (RECIST v1.1). Overall survival (OS)...

Full description

Saved in:

Bibliographic Details
Published in:	NPJ precision oncology Vol. 9; no. 1; pp. 24 - 7
Main Authors:	Patel, Sandip P., Cano-Linson, Eleanor, Chae, Young Kwang, Schokrpur, Shiruyeh, Lao, Christopher D., Powers, Benjamin C., Victor, Adrienne I., Onitilo, Adedayo A., Shin, Sarah, Takebe, Naoko, Threlkel, Sara, McLeod, Christine M., Chen, Helen X., Sharon, Elad, Othus, Megan, Ryan, Christopher W., Blanke, Charles D., Kurzrock, Razelle
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 24.01.2025 Nature Publishing Group Nature Portfolio
Subjects:	692/308/409 692/4028/67/1813/1349 Cancer Research Diarrhea Gene Therapy Human Genetics Immunotherapy Internal Medicine Lung cancer Medical research Medicine Medicine & Public Health Metastasis Monoclonal antibodies Oncology Patients Skin cancer Targeted cancer therapy Toxicity Tumors
ISSN:	2397-768X, 2397-768X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!